Position in ZTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$122,242,733
+$21,701,106 QoQ
Shares Held
1,034,115
+29.4% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $407,067,928 across 27 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (30.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
1,493,813 | $196,794,922 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
1,034,115 | $122,242,733 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
72,715 | $43,118,539 | |
| 4 | VTRS |
Viatris Inc
|
1,108,006 | $14,969,159 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
391,587 | $11,794,600 | |
| 6 | ALKS |
Alkermes plc.
|
239,671 | $8,474,765 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
683,997 | $3,693,583 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
117,894 | $2,664,403 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $122,242,733 | 1,034,115 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $100,541,627 | 799,091 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $84,663,823 | 578,621 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $70,497,820 | 452,054 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $86,686,907 | 526,492 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $49,399,886 | 303,197 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $53,637,670 | 274,530 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $63,522,917 | 366,422 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $54,608,804 | 322,728 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $100,687,910 | 510,148 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $128,445,953 | 738,280 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $99,359,486 | 576,967 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $58,813,238 | 353,360 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $66,367,804 | 452,868 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $46,975,009 | 316,778 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $63,440,301 | 369,075 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $54,894,400 | 291,078 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $57,870,737 | 237,146 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $46,246,865 | 238,214 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $46,253,247 | 248,193 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $40,972,988 | 260,179 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $44,009,925 | 265,921 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $37,962,667 | 229,562 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $25,766,946 | 188,025 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $19,287,037 | 163,880 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||